Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24010758 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Pulak R Manna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Triple Negative Breast Neoplasms, Mammary Neoplasms, Animal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention Research Institute of Texas and Welch Endowed Chair in Biochemistry, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Breast cancer (BC) is primarily triggered by estrogens, especially 17β-estradiol (E2), which are synthesized by the aromatase enzyme. While all steroid hormones are derived from cholesterol, the rate-limiting step in steroid biosynthesis is mediated by the steroidogenic acute regulatory (StAR) protein. Herein, we demonstrate that StAR mRNA expression was aberrantly high in human hormone-dependent BC (MCF7, MDA-MB-361, and T-47D), modest in hormone-independent triple negative BC (TNBC; MDA-MB-468, BT-549, and MDA-MB-231), and had little to none in non-cancerous mammary epithelial (HMEC, MCF10A, and MCF12F) cells. In contrast, these cell lines showed abundant expression of aromatase (CYP19A1) mRNA. Immunofluorescence displayed qualitatively similar patterns of both StAR and aromatase expression in various breast cells. Additionally, three different transgenic (Tg) mouse models of spontaneous breast tumors, i.e., MMTV-Neu, MMTV-HRAS, and MMTV-PyMT, demonstrated markedly higher expression of StAR mRNA/protein in breast tumors than in normal mammary tissue. While breast tumors in these mouse models exhibited higher expression of ERα, ERβ, and PR mRNAs, their levels were undetected in TNBC tumors. Accumulation of E2 in plasma and breast tissues, from MMTV-PyMT and non-cancerous Tg mice, correlated with StAR, but not with aromatase, signifying the importance of StAR in governing E2 biosynthesis in mammary tissue. Treatment with a variety of histone deacetylase inhibitors (HDACIs) in primary cultures of enriched breast tumor epithelial cells, from MMTV-PyMT mice, resulted in suppression of StAR and E2 levels. Importantly, inhibition of StAR, concomitant with E2 synthesis, by various HDACIs, at clinical and preclinical doses, in MCF7 cells, indicated therapeutic relevance of StAR in hormone-dependent BCs. These findings provide insights into the molecular events underlying the differential expression of StAR in human and mouse cancerous and non-cancerous breast cells/tissues, highlighting StAR could serve not only as a novel diagnostic maker but also as a therapeutic target for the most prevalent hormone-sensitive BCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA.
- Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA.
- Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA.
- Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX 79430, USA.
- Neurology, Departments of School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
- Public Health Department of Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
ORCID-Profile: Jangampalli Adi Pradeepkiran, Isabel Castro-Piedras, P Hemachandra Reddy
Förderung
- Cancer Prevention Research Institute of Texas and Welch Endowed Chair in Biochemistry
- NIH HHS
- National Institutes of Health
- Cancer Prevention Research Institute of Texas
- Welch Endowed Chair in Biochemistry
- Department of Internal Medicine
Zitieren
APA
Manna, P. R., Ramachandran, S., Pradeepkiran, J. A., Molehin, D., Castro-Piedras, I., Pruitt, K., Ganapathy, V., & Reddy, P. H. (2023). Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010758
Vancouver
Manna PR, Ramachandran S, Pradeepkiran JA, Molehin D, Castro-Piedras I, Pruitt K, et al. Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010758
BibTeX
@article{Manna2023,
author = {Manna, Pulak R and Ramachandran, Sabarish and Pradeepkiran, Jangampalli Adi and Molehin, Deborah and Castro-Piedras, Isabel and Pruitt, Kevin and Ganapathy, Vadivel and Reddy, P Hemachandra},
title = {Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24010758}
}
EUVIMED